At a Reference Centre Directors' meeting, Professor Bloom stated that it was "difficult to avoid the argument that non-HT [non-heat treated] constitutes a risk."
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Professor Arthur L Bloom